Penumbra Inc. Board Changes and Officer Compensation
Ticker: PEN · Form: 8-K · Filed: Aug 27, 2025 · CIK: 1321732
| Field | Detail |
|---|---|
| Company | Penumbra Inc (PEN) |
| Form Type | 8-K |
| Filed Date | Aug 27, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $2 million, $2.5 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-change, officer-compensation
Related Tickers: PEN
TL;DR
Penumbra's board sees a director exit; officer pay details disclosed.
AI Summary
Penumbra, Inc. announced on August 22, 2025, a change in its board of directors, with the departure of director Dr. Aris T. Papageorge. The company also reported on compensatory arrangements for its officers. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine board changes and compensation disclosures, which typically carry low immediate risk.
Key Players & Entities
- Penumbra, Inc. (company) — Filer of the 8-K report
- Dr. Aris T. Papageorge (person) — Departing director
- August 22, 2025 (date) — Date of earliest event reported
FAQ
Who is Dr. Aris T. Papageorge and what was his role at Penumbra, Inc.?
Dr. Aris T. Papageorge was a director at Penumbra, Inc. His departure is noted in the filing as of August 22, 2025.
What specific items are covered in this 8-K filing?
This 8-K filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD Disclosure, and Financial Statements and Exhibits.
When was the date of the earliest event reported in this filing?
The date of the earliest event reported is August 22, 2025.
What is Penumbra, Inc.'s Standard Industrial Classification (SIC) code?
Penumbra, Inc.'s SIC code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
What is the exact name of the company filing this report?
The exact name of the company filing this report is Penumbra, Inc.
Filing Stats: 922 words · 4 min read · ~3 pages · Grade level 10.8 · Accepted 2025-08-27 09:05:02
Key Financial Figures
- $0.001 — ich registered Common Stock, Par value $0.001 per share PEN The New York Stock Exchan
- $2 million — anuary 1, 2024 amounts to approximately $2 million. The transactions between the Company a
- $2.5 million — ith an aggregate value of approximately $2.5 million under the Company's Amended and Restate
Filing Documents
- pen-20250822.htm (8-K) — 32KB
- snpresidentpressrelease.htm (EX-99.1) — 10KB
- image_0.jpg (GRAPHIC) — 110KB
- 0001321732-25-000101.txt ( ) — 311KB
- pen-20250822.xsd (EX-101.SCH) — 2KB
- pen-20250822_lab.xml (EX-101.LAB) — 21KB
- pen-20250822_pre.xml (EX-101.PRE) — 12KB
- pen-20250822_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On August 27, 2025, the Company issued a press release in connection with Ms. Narayan's appointment as President of the Company. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01, including the attached exhibit, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release of Penumbra, Inc. dated August 27, 2025. 104 Cover Page Interactive Data File (formatted as Inline Extensible Business Reporting Language).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Penumbra, Inc. Date: August 27, 2025 By: /s/ Johanna Roberts Johanna Roberts Executive Vice President, General Counsel and Secretary